脑部放疗,上午比下午敏感许多!
; S; B; P6 |% E' Y) A6 r8 N9 Q% e- B/ n
& E2 c) q: E' R$ U
- E" c: d! i5 RCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.# C, O* e) ~; D* E3 Q- F+ o
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
5 A5 N1 Y6 K( C/ t. ?8 G* Z1 ]Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.& K8 ^" J$ p' h- C1 e
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
4 Z# D8 X6 d2 |& f/ t. v$ C: w& p
6 u1 h( z2 d# E5 a6 O4 JAbstract
9 f" t: r9 o) o. T5 u( |5 KBACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.; D, A0 k s5 V+ }2 q+ a2 r2 W- Q
; C( X! I* o: {9 [2 @
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.$ p, ~' B4 @* @/ p4 ]& D, s4 F
5 n2 \" {6 F6 K& j- f- S! [RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026). v4 x% q* \0 v* D( n
3 s1 E4 p9 o+ ]- p' b" G, K4 sCONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series." p& ~- e& O% ]# w
$ f! X1 G) Y5 u
|